Benzinga | Aug 5, 2021 07:20AM EDT

Concert Pharmaceuticals Q2 EPS $0.16 Up From $(0.41) YoY, Sales $32.02M Up From $6.39M YoY

Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly earnings of $0.16 per share. This is a 139.02 percent increase over losses of $(0.41) per share from the same period last year. The company reported $32.02 million in sales this quarter. This is a 401.28 percent increase over sales of $6.39 million the same period last year.